Table 1 |
|
|
Patients' baseline characteristics (n = 61) |
|
|
Variable |
|
|
|
|
|
Mean age (years) |
63.18 ± 10.60 |
|
Sex (M/F) (%) |
70.5/29.5 |
|
Chronic HBV infection (%) |
27.87 |
|
Chronic HCV infection (%) |
49.18 |
|
Alcohol (%) |
6.60 |
|
Other (%) |
16.35 |
|
One lesion/multiple lesions (%) |
55.93/44.07 |
|
Mean tumor size (cm) |
5.25 ± 3.93 |
|
Mean serum AFP level (ng/mL) |
4265.24 ± 10672.40 |
|
Tumor differentiation: |
|
|
Well/moderate/poorly (%) |
36/47.5/8.2 |
|
AFP immunostaining (positive/negative) (%) |
29.27/70.73 |
|
Mean Ki67 score |
14.42 ± 15.74 |
|
Mean TUNEL score |
27.67 ± 26.99 |
|
SCCA immunostaining (positive/negative) (%) |
83.6/16.4 |
|
SCCA scoring (%) |
|
|
Score 1 |
50 |
|
Score 2 |
19.7 |
|
Score 3 |
20.3 |
|
Liver transplantation (%) |
27.87 |
|
Hepatic resection (%) |
44.26 |
|
Chemoembolization (%) |
36.39 ± 33.66 |
|
Mean survival (months) |
36.39 ± 33.66 |
|
|
|
|
Abbreviations: M/F = male/female; HBV = hepatitis B virus; HCV = hepatitis C virus; AFP = alpha feto protein; TUNEL = Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling; SCCA = squamous cellular carcinoma antigen |
|
|
Schmilovitz-Weiss et al. Diagnostic Pathology 2011 6:121 doi:10.1186/1746-1596-6-121 |
|